000 01567 a2200481 4500
005 20250515025323.0
264 0 _c20060706
008 200607s 0 0 eng d
022 _a1354-523X
024 7 _a10.1111/j.1601-0825.2005.01195.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAframian, D J
245 0 0 _aPilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer.
_h[electronic resource]
260 _bOral diseases
_cMay 2006
300 _a297-300 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBlood Pressure
650 0 4 _aBody Temperature
650 0 4 _aChronic Disease
650 0 4 _aDental Caries
_xetiology
650 0 4 _aFemale
650 0 4 _aHeart Rate
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscarinic Agonists
_xpharmacology
650 0 4 _aParotid Diseases
_xdrug therapy
650 0 4 _aPilocarpine
_xpharmacology
650 0 4 _aSaliva
_xmetabolism
650 0 4 _aSecretory Rate
_xdrug effects
650 0 4 _aSialadenitis
_xdrug therapy
650 0 4 _aStatistics, Nonparametric
650 0 4 _aThyroid Neoplasms
_xradiotherapy
650 0 4 _aXerostomia
_xetiology
700 1 _aHelcer, M
700 1 _aLivni, D
700 1 _aMarkitziu, A
773 0 _tOral diseases
_gvol. 12
_gno. 3
_gp. 297-300
856 4 0 _uhttps://doi.org/10.1111/j.1601-0825.2005.01195.x
_zAvailable from publisher's website
999 _c16300542
_d16300542